B

Bio-Rad Laboratories IncClass A

BIO

340.87
USD
2.39
(0.71%)
Market Closed
Volume
7,362
EPS
0
Div Yield
0
P/E
-7
Market Cap
9,496,090,594
Related Instruments
ABBV
4.380
(2.36%)
189.700 USD
ABT
4.220
(3.98%)
110.150 USD
AMGN
2.78
(0.84%)
335.22 USD
B
BAX
0.190
(0.53%)
36.000 USD
BDX
-4.995
(-2.07%)
236.055 USD
BSX
1.315
(1.78%)
75.170 USD
EW
-1.220
(-1.94%)
61.830 USD
ISRG
6.98
(1.57%)
451.27 USD
JNJ
2.930
(1.86%)
160.770 USD
REGN
13.14
(1.22%)
1,091.19 USD
TMO
9.03
(1.47%)
621.78 USD
News

Title: Bio/Rad Laboratories IncClass A

Sector: Healthcare
Industry: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.